Xiaotun Zhang
Overview
Explore the profile of Xiaotun Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
2136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su S, Cao J, Meng X, Liu R, Vander Ark A, Woodford E, et al.
Cancer Lett
. 2021 Nov;
525:170-178.
PMID: 34752846
Enzalutamide resistance has been observed in approximately 50% of patients with prostate cancer (PCa) bone metastases. Therefore, there is an urgent need to investigate the mechanisms and develop strategies to...
2.
Zhang X, Tretiakova M
Int J Surg Pathol
. 2020 Sep;
29(4):427-432.
PMID: 32909465
Biphasic squamoid alveolar renal cell carcinoma (BSARCC) is a recently described kidney cancer entity with <60 published cases so far. Some unique features of BSARCC include distinct squamoid and alveolar...
3.
Sauter J, Lehrke H, Zhang X, Al Badri O, Rodriguez-Gutierrez R, Delivanis D, et al.
Am J Clin Pathol
. 2019 Jul;
152(4):502-511.
PMID: 31305880
Objectives: Long-term follow-up is important for determining performance characteristics of thyroid fine-needle aspiration (FNA). Methods: Histologic or 3 or more years of clinical follow-up was used to calculate performance characteristics...
4.
Alsinnawi M, Zhang A, Bianchi-Frias D, Burns J, Cho E, Zhang X, et al.
Prostate Cancer Prostatic Dis
. 2019 Mar;
22(4):560-568.
PMID: 30890759
Background: SLCO-encoded transporters have been associated with progression to castration-resistant prostate cancer (CRPC) after initiation of androgen deprivation therapy (ADT). Although expressed at lower levels than in CRPC tissues, SLCO-encoded...
5.
Zhang X, Howell J, Huang Y
Endocr Pathol
. 2018 Sep;
29(4):346-350.
PMID: 30203321
Fine-needle aspiration (FNA) cytology coupled with needle-wash thyroglobulin (FNA-Tg) testing is recommended for cervical lymph node (LN) biopsies in patients with a history of papillary thyroid carcinoma (PTC). However, the...
6.
Mostaghel E, Zhang A, Hernandez S, Marck B, Zhang X, Tamae D, et al.
Clin Cancer Res
. 2018 Sep;
25(1):426-439.
PMID: 30181386
Purpose: Tumor androgens in castration-resistant prostate cancer (CRPC) reflect intratumoral synthesis or adrenal androgens. We used C.B.-17 SCID mice in which we observed adrenal CYP17A activity to isolate the impact...
7.
Zhang X, Jones A, Jenkins S, Huang Y
Endocr Pathol
. 2018 Jan;
29(1):43-48.
PMID: 29349725
Primary ovarian carcinoid tumors are rare neoplasms that constitute less than 0.1% of all ovarian carcinomas. However, carcinoid tumors metastatic to ovaries are more common. Cell proliferative rate is an...
8.
Nghiem B, Zhang X, Lam H, True L, Coleman I, Higano C, et al.
Asian J Urol
. 2017 Dec;
3(4):223-228.
PMID: 29264190
Objective: Although the utility of immunohistochemistry (IHC) for assessing mismatch repair (MMR) protein expression has been demonstrated in solid tumors including primary prostate cancer (PCa), its utility has not been...
9.
Bluemn E, Coleman I, Lucas J, Coleman R, Hernandez-Lopez S, Tharakan R, et al.
Cancer Cell
. 2017 Oct;
32(4):474-489.e6.
PMID: 29017058
Androgen receptor (AR) signaling is a distinctive feature of prostate carcinoma (PC) and represents the major therapeutic target for treating metastatic prostate cancer (mPC). Though highly effective, AR antagonism can...
10.
Nguyen H, Vessella R, Morrissey C, Brown L, Coleman I, Higano C, et al.
Prostate
. 2017 Feb;
77(6):654-671.
PMID: 28156002
Background: Metastatic prostate cancer is a common and lethal disease for which there are no therapies that produce cures or long-term durable remissions. Clinically relevant preclinical models are needed to...